Skip to content
Weight Loss Index

Weight Loss Index

Weight Loss Index is an independent industry database and research platform for the global obesity treatment and weight loss therapeutics market.

The project organizes structured information about companies, drugs, active ingredients, mechanisms, clinical programs, regulatory milestones, treatment channels, and commercial relationships that shape the industry.

Its focus is industry reference value: durable records, source-aware context, and clear links between related entities.

Database areas

Section titled “Database areas”
  • Foundations - core concepts for reading obesity treatment records, including ingredient/product distinctions, regulatory status, clinical interpretation, and market access context.
  • Companies - pharmaceutical, biotechnology, and adjacent organizations active in the obesity treatment market.
  • Drugs and products - approved products and credible development-stage assets connected to ingredients, mechanisms, companies, and regulatory records.
  • Active ingredients - ingredient-level records that connect brands, products, mechanisms, development programs, and commercial relationships.
  • Mechanisms - mechanism and drug-class pages that explain how products and programs relate to one another.
  • Clinical programs - development programs, trial-linked assets, indications studied, sponsors, and dated status context.
  • Regulatory milestones - approvals, submissions, label changes, safety communications, and jurisdiction-specific regulatory events.